MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Corticobasal degeneration (CBD)"

  • 2017 International Congress

    The Corticobasal Degeneration Functional Rating Scale (CBD-FS)

    A. Lang, G. Stebbins, A. Boxer (Toronto, Canada)

    Objective: To develop a patient/care giver-reported scale that is capable of assessing functional disability in CBD that can be easily and reliably used in clinical…
  • 2017 International Congress

    Signal intensity of cerebral gyri in corticobasal degeneration on phase difference enhanced MR images: Comparison with progressive supranuclear palsy and Parkinson’s disease

    M. Miyata, S. Kakeda, T. Yoneda, S. Ide, K. Watanabe, J. Moriya, H. Narimatsu, T. Sato, K. Okada, H. Adachi, Y. Korogi (Kitakyushu, Japan)

    Objective: We evaluated the signal intensity of the cerebral gyri (CG) on phase difference enhanced imaging (PADRE) for the patients with corticobasal degeneration (CBD), progressive…
  • 2016 International Congress

    A longitudinal observational study of a cohort of patients with PSP/CBD: The JALPAC project

    T. Tokuda, T. Ikeuchi, H. Takigawa, I. Aiba, T. Shimohata, M. Morita, O. Onodera, S. Murayama, K. Nakashima (Kyoto, Japan)

    Objective: To identify PSP/CBD progression biomarkers both to improve understanding of disease etiology and course, and to provide crucial tools to enhance the likelihood of…
  • 2016 International Congress

    “Words untold”

    P.M. Iyer, B. McGuiness, J. Scott, S. Manning, A. Chalisseri, D. Olszewska, M. Farrell, T. Lynch (Dublin, Ireland)

    Objective: To highlight the salient clinical and pathologic features of primary progressive apraxia of speech through a clinical case presentation. Background: Apraxia of speech is…
  • 2016 International Congress

    Dorsal simultanagnosia as a cortical sign in the tauopathy spectrum

    B. Bergmans, O. Deryck, R. Bruffaerts (Brugge, Belgium)

    Objective: Clinical characterization of a tauopathy spectrum patient. Background: In recent years phenotypic overlap has been demonstrated between patients with progressive supranuclear palsy (PSP) pathology…
  • 2016 International Congress

    Overlapping corticobasal syndromes: The many faces of the Armstrong criteria

    A. Pilotto, W. Maetzler, M. Synofzik, E. Schaeffer, C. Schulte, M.A. Hobert, K. Srulijes, T. Gasser, D. Berg (Tübingen, Germany)

    Objective: To evaluate the prevalence and clinical presentation of corticobasal variants listed in the new Armstrong criteria, exploring their overlap with progressive supranuclear palsy (PSP),…
  • 2016 International Congress

    Oxysterol and chitotriosidase as biomarkers for atypical Parkinsonian symptoms?

    M. Schuberth, G. Nübling, J. Hauer, T. Marquardt, S. Lorenzl (München, Germany)

    Objective: The aim of the study is to establish chitotriosidase and oxysterols as a biomarker for atypical Parkinsonian syndromes in order to make a distinction…
  • 2016 International Congress

    Subjective report does not predict objective swallow impairment in atypical Parkinsonian syndromes

    L. Shahgholi, S. De Jesus, A. Paterson, W. Deeb, N.R. McFarland, K. Hegland (Gainesville, FL, USA)

    Objective: Swallow and speech disturbances are common in patients with atypical parkinsonism. The emergence of swallowing problems, or dysphagia, is associated with increased morbidity and…
  • 2016 International Congress

    Clinical predictors of progressive supranuclear palsy (PSP) pathology in PSP syndrome

    I. Aiba, Y. Saito, Y. Yokokawa, M. Kenjo, T. Katayama, R. Hashimoto, S. Sakakibara, A. Inukai, M. Mimuro, Y. Iwasaki, M. Yoshida (Nagoya, Japan)

    Objective: To elucidate specific clinical features of progressive supranuclear palsy (PSP) pathology in PSP syndrome. Background: PSP syndrome (PSPS) is the clinical hallmark of PSP;…
  • 2016 International Congress

    Atypical Parkinsonian disorders: Insights for a differential diagnosis through the analysis of oculomotor profile in MSA, PSP and CBD patients

    F. Rosini, G. Lucii, P. Federighi, E. Pretegiani, F. Giannini, R. Rocchi, A. Federico, A. Rufa (Siena, Italy)

    Objective: To determine peculiar changes in oculomotor profile that may help in distinguishing atypical parkinsonism with overlapping clinical features. Background: Atypical Parkinsonian disorders (APDs) include…
  • « Previous Page
  • 1
  • …
  • 9
  • 10
  • 11
  • 12
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley